C, E., M, D., & L, D. (2026). Comparative in vitro efficacy of aztreonam-avibactam and other alternatives (cefepime-taniborbactam, cefepime-zidebactam, and cefiderocol) against metallo-β-lactamase-producing Enterobacterales isolated in 2024 in France. Antimicrobial agents and chemotherapy, 70(5), e0017626. https://doi.org/10.1128/aac.00176-26
Chicago Style (17th ed.) CitationC, Emeraud, Dutkiewicz M, and Dortet L. "Comparative in Vitro Efficacy of Aztreonam-avibactam and Other Alternatives (cefepime-taniborbactam, Cefepime-zidebactam, and Cefiderocol) Against Metallo-β-lactamase-producing Enterobacterales Isolated in 2024 in France." Antimicrobial Agents and Chemotherapy 70, no. 5 (2026): e0017626. https://doi.org/10.1128/aac.00176-26.
MLA (9th ed.) CitationC, Emeraud, et al. "Comparative in Vitro Efficacy of Aztreonam-avibactam and Other Alternatives (cefepime-taniborbactam, Cefepime-zidebactam, and Cefiderocol) Against Metallo-β-lactamase-producing Enterobacterales Isolated in 2024 in France." Antimicrobial Agents and Chemotherapy, vol. 70, no. 5, 2026, p. e0017626, https://doi.org/10.1128/aac.00176-26.